TCRX Tscan Therapeutics, Inc.

Fundamentals / CIK 0001783328 / USD

Tscan Therapeutics, Inc. reported $5.19M in revenue and a net loss of $115.1M for the trailing twelve months ended September 30, 2026 (down 76.7% year over year), with a -2246.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TCRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$34.45M$17.22M$0-$123.1MFY 2020 Revenue: $1.08MFY 2020 Net Income: -$26.13M2020FY 2021 Revenue: $10.14MFY 2021 Net Income: -$48.62M2021FY 2022 Revenue: $13.54MFY 2022 Net Income: -$66.22M2022FY 2023 Revenue: $21.05MFY 2023 Net Income: -$89.22M2023FY 2024 Revenue: $2.82MFY 2024 Net Income: -$127.5M2024FY 2025 Revenue: $10.32MFY 2025 Net Income: -$129.8M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $10.32M $2.82M $21.05M $13.54M $10.14M $1.08M
Research & Development $114.2M $107.3M $88.15M $59.82M $44.95M $20.58M
Total Operating Expenses $146.1M $137.6M $114.5M $80.17M $58.78M $27.32M
Operating Income -$135.8M -$134.8M -$93.46M -$66.64M -$48.64M -$26.23M
EBITDA -$132.9M -$130.7M -$88.06M -$61.54M -$45.34M -$25.03M
Interest Expense $2.77M $3.65M $3.76M $1.18M -- --
Income Tax Expense $0 -- -- -- -- --
Net Income -$129.8M -$127.5M -$89.22M -$66.22M -$48.62M -$26.13M
Basic EPS -$1.00 -$1.14 -$1.36 -$2.75 -$4.17 -$28.52
Diluted EPS -$1.00 -$1.14 -$1.36 -$2.75 -$4.17 -$28.52
Basic Shares Outstanding 129.8M 112.0M 65.6M 24.0M 11.7M 916.0K
Diluted Shares Outstanding 129.8M 112.0M 65.6M 24.0M 11.7M 916.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $586K $1.05M $982K $2.57M $2.51M $3.08M $2.17M $665K
Research & Development $25.29M $23.40M $21.90M $20.04M $31.69M $32.63M $29.79M $29.35M
Total Operating Expenses $33.62M $31.54M $30.12M $26.43M $39.56M $41.73M $38.42M $37.38M
Operating Income -$33.03M -$30.49M -$29.14M -$23.86M -$37.05M -$38.65M -$36.25M -$36.71M
EBITDA -$32.35M -$29.79M -$28.45M -$23.14M -$36.28M -$37.95M -$35.57M -$36.00M
Interest Expense $775K $699K $689K $702K $699K $689K $679K $784K
Net Income -$33.09M -$30.36M -$28.67M -$22.98M -$35.71M -$36.95M -$34.13M -$35.81M
Basic EPS -$0.25 -$0.23 -$0.22 -- -$0.28 -$0.28 -$0.26 --
Diluted EPS -$0.25 -$0.23 -$0.22 -- -$0.28 -$0.28 -$0.26 --
Basic Shares Outstanding 130.0M 129.9M 129.9M -- 129.8M 129.7M 129.7M --
Diluted Shares Outstanding 130.0M 129.9M 129.9M -- 129.8M 129.7M 129.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $152.4M $178.7M $133.4M $120.0M $161.4M $34.79M
Short-Term Investments -- $111.4M $58.69M -- -- --
Cash & Short-Term Investments $152.4M $290.1M $192.0M $120.0M $161.4M $34.79M
Total Current Assets $157.2M $292.7M $194.2M $124.1M $165.7M $36.45M
Property, Plant & Equipment, Net $8.71M $7.24M $7.74M $10.10M $11.77M $5.66M
Total Non-Current Assets $71.58M $78.40M $77.91M $74.96M $22.45M $13.29M
Total Assets $228.8M $371.1M $272.1M $199.1M $188.1M $49.74M
Accounts Payable $1.24M $4.28M $2.37M $2.91M $1.76M $2.91M
Short-Term Debt -- -- $3.35M -- -- --
Deferred Revenue (Current) $2.62M $11.70M $10.14M $3.87M $11.41M $10.63M
Total Current Liabilities $18.70M $35.96M $29.82M $17.30M $21.34M $17.45M
Long-Term Debt $32.53M $32.07M $26.70M $29.29M -- --
Deferred Revenue (Non-Current) -- $1.25M $5.62M -- $1.50M $8.82M
Other Non-Current Liabilities -- $135K -- $49K $97K $238K
Total Non-Current Liabilities $86.97M $94.19M $91.46M $82.35M $5.99M $15.07M
Total Liabilities $105.7M $130.1M $121.3M $99.66M $27.33M $32.52M
Total Debt (incl. Leases) $94.14M $97.38M $92.43M $85.98M $6.04M $7.43M
Common Stock -- -- -- -- -- $1.0K
Retained Earnings -$504.9M -$375.1M -$247.6M -$158.4M -$92.16M -$43.53M
Accumulated Other Comp. Income -- $51K -- -- -- --
Total Stockholders' Equity $123.1M $241.0M $150.9M $99.43M $160.8M -$42.46M
Total Equity $123.1M $241.0M $150.9M $99.43M $160.8M -$42.46M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $73.04M $100.2M $128.1M $152.4M $169.5M $169.4M $154.1M $178.7M
Short-Term Investments -- -- -- -- $14.95M $48.65M $97.58M $111.4M
Cash & Short-Term Investments $73.04M $100.2M $128.1M $152.4M $184.5M $218.0M $251.7M $290.1M
Total Current Assets $76.78M $104.4M $132.8M $157.2M $188.2M $221.1M $254.8M $292.7M
Property, Plant & Equipment, Net $7.11M $7.74M $8.12M $8.71M $9.30M $9.52M $8.35M $7.24M
Total Non-Current Assets $64.62M $67.05M $69.22M $71.58M $74.06M $77.43M $77.87M $78.40M
Total Assets $141.4M $171.5M $202.0M $228.8M $262.2M $298.6M $332.7M $371.1M
Accounts Payable $1.24M $3.12M $2.30M $1.24M $6.35M $4.54M $4.97M $4.28M
Short-Term Debt $15.70M $11.71M -- -- -- -- -- --
Deferred Revenue (Current) -- $586K $1.64M $2.62M $5.19M $7.70M $10.27M $11.70M
Total Current Liabilities $37.82M $30.96M $19.97M $18.70M $29.21M $31.32M $29.82M $35.96M
Long-Term Debt $17.27M $21.07M $32.65M $32.53M $32.41M $32.30M $32.18M $32.07M
Deferred Revenue (Non-Current) -- -- -- -- -- -- $501K $1.25M
Other Non-Current Liabilities -- -- -- -- $278K $113K $124K $135K
Total Non-Current Liabilities $65.57M $71.47M $85.10M $86.97M $89.00M $90.53M $92.69M $94.19M
Total Liabilities $103.4M $102.4M $105.1M $105.7M $118.2M $121.8M $122.5M $130.1M
Total Debt (incl. Leases) $89.28M $90.89M $92.54M $94.14M $95.62M $96.70M $97.04M $97.38M
Retained Earnings -$597.0M -$563.9M -$533.5M -$504.9M -$481.9M -$446.2M -$409.2M -$375.1M
Accumulated Other Comp. Income -- -- -- -- $2.0K -$4.0K -$4.0K $51K
Total Stockholders' Equity $38.01M $69.02M $96.92M $123.1M $144.0M $176.7M $210.2M $241.0M
Total Equity $38.01M $69.02M $96.92M $123.1M $144.0M $176.7M $210.2M $241.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$129.8M -$127.5M -$89.22M -$66.22M -$48.62M -$26.13M
Depreciation & Amortization $2.90M $4.10M $5.40M $5.10M $3.30M $1.20M
Stock-Based Compensation $11.71M $9.55M $5.21M $4.55M $2.52M $515K
Change in Payables -$3.01M $1.99M -$52K $528K $10K $1.13M
Operating Cash Flow -$135.3M -$110.8M -$61.36M -$66.50M -$48.68M -$3.02M
Capital Expenditure -$4.41M -$3.83M -$3.15M -$4.22M -$9.94M -$4.24M
Free Cash Flow -$139.7M -$114.6M -$64.50M -$70.73M -$58.62M -$7.26M
Purchases of Investments -$87.47M -$241.4M -$77.61M -- -- --
Investing Cash Flow $109.4M -$52.61M -$60.76M -$4.22M -$9.94M -$4.24M
Common Stock Issued -- $33.13M $42.41M $193K -- --
Financing Cash Flow -$336K $208.8M $135.4M $29.36M $189.7M $288K
Net Change in Cash -$26.28M $45.33M $13.33M -$41.37M $131.1M -$6.97M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$33.09M -$30.36M -$28.67M -$22.98M -$35.71M -$36.95M -$34.13M -$35.81M
Depreciation & Amortization $678K $699K $693K $723K $767K $698K $678K $711K
Stock-Based Compensation $2.08M $2.36M $2.46M $2.01M $3.01M $3.27M $3.41M $2.71M
Change in Payables -$1.88M $843K $1.04M -$5.07M $1.93M -$435K $558K $983K
Operating Cash Flow -$27.08M -$27.54M -$24.28M -$32.00M -$32.46M -$33.27M -$37.59M -$27.41M
Capital Expenditure -$41K -$493K -$70K -$171K -$1.43M -$1.28M -$1.53M -$888K
Free Cash Flow -$27.12M -$28.03M -$24.35M -$32.17M -$33.89M -$34.55M -$39.12M -$28.30M
Purchases of Investments -- -- -- $0 $1.0K -$26.53M -$60.94M -$47.33M
Investing Cash Flow -$41K -$465K -$70K $14.83M $32.58M $48.44M $13.53M $27.29M
Financing Cash Flow -- -- -- $73K $0 $116K -$525K $45.69M
Net Change in Cash -$27.12M -$27.90M -$24.35M -$17.10M $112K $15.29M -$24.58M $45.57M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -1315.4% -4787.7% -444.0% -492.3% -479.6% -2417.8%
Net Profit Margin -1256.8% -4527.7% -423.9% -489.3% -479.5% -2408.0%
Return on Equity (ROE) -105.4% -52.9% -59.1% -66.6% -30.2% --
Return on Assets (ROA) -56.7% -34.4% -32.8% -33.3% -25.8% -52.5%
Current Ratio 8.41x 8.14x 6.51x 7.17x 7.76x 2.09x
Quick Ratio 8.15x 8.07x 6.44x 6.94x 7.56x 1.99x
Debt to Equity 0.76x 0.40x 0.61x 0.86x 0.04x --
Revenue Growth (YoY) +266.7% -86.6% +55.5% +33.5% +834.7% --
5Y Revenue / Share Growth -93.3% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -2246.8% -1695.1% -1408.7% -1315.4% -1765.0% -2072.1% -3159.9% -4787.7%
Net Profit Margin -2219.2% -1655.4% -1360.6% -1256.8% -1693.0% -1964.9% -2974.1% -4527.7%
Return on Equity (ROE) -302.8% -170.6% -128.3% -105.4% -99.0% -77.4% -62.6% -52.9%
Return on Assets (ROA) -81.4% -68.7% -61.5% -56.7% -54.4% -45.8% -39.5% -34.4%
Current Ratio 2.03x 3.37x 6.65x 8.41x 6.44x 7.06x 8.55x 8.14x
Quick Ratio 1.93x 3.23x 6.41x 8.15x 6.32x 6.96x 8.44x 8.07x
Debt to Equity 2.35x 1.32x 0.95x 0.76x 0.66x 0.55x 0.46x 0.40x
Revenue Growth (YoY) -76.7% -65.8% -54.8% +286.0% +139.4% +473.9% +283.6% -90.8%
Source: SEC EDGAR CompanyFacts (CIK 0001783328) · from June 30, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:06 UTC · Open in terminal